Medicare Obesity Coverage Expansion (Regulatory): The Centers for Medicare & Medicaid Services (CMS) announced that beginning in April 2026, Medicare will cover GLP-1 medications for beneficiaries with obesity and qualifying comorbidities via the BALANCE Model and Section 402 demonstrations, marking a reversal of the long-standing statutory ban on weight-loss drug coverage
But while GHK-cu could help your skin, Giannelli cautions that it cant replace the basics
GLP-3 medications like retatrutide may be appropriate for individuals who: Have experienced plateaus with GLP-1 medications Struggle with metabolic resistance Want a more comprehensive, physician-guided solution For additional insight into how hormone-based therapies are used at Inner Glow, explore our advanced weight loss treatments
Reveal your best self today
These observations were further elaborated by McDonald and Phillips, who reported in 1969 that the experimental NMR spectra of many denatured proteins (lysozyme, ribonuclease, pepsin, trypsin, apoferredoxin, apo-flavodoxin, oxytocin, and cytochrome c ) were closely matched by the spectra computed by summing the spectra of the equivalent free amino acids, indicating the random coil-like structure of unfolded forms of globular proteins (McDonald and Phillips, 1969
An advanced antioxidant serum harnessing the regenerative power of Copper Tripeptide-1 (GHK-Cu) to stimulate collagen and elastin synthesis, combined with Ubiquinone (Coenzyme Q10) for cellular renewal and Niacinamide to brighten, refine and reinforce the skin barrier for visibly younger-looking skin
